X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (134) 134
male (103) 103
humans (94) 94
index medicus (79) 79
azocines - pharmacology (77) 77
pharmacology & pharmacy (76) 76
azocines - therapeutic use (68) 68
rats (67) 67
alkaloids - pharmacology (64) 64
mice (47) 47
neurosciences (43) 43
quinolizines - pharmacology (43) 43
dose-response relationship, drug (42) 42
nicotinic agonists - pharmacology (42) 42
azocines (41) 41
female (41) 41
nicotine (40) 40
receptors, nicotinic - metabolism (38) 38
quinolizines (37) 37
varenicline (37) 37
cytisine (35) 35
nicotine - pharmacology (32) 32
alkaloids - therapeutic use (29) 29
receptors, nicotinic - drug effects (28) 28
smoking cessation - methods (28) 28
adult (27) 27
quinolizines - therapeutic use (25) 25
acetylcholine-receptors (24) 24
rats, sprague-dawley (24) 24
nicotinic antagonists - pharmacology (22) 22
psychiatry (22) 22
alkaloids - metabolism (21) 21
azocines - administration & dosage (20) 20
mice, inbred c57bl (20) 20
nicotine - antagonists & inhibitors (20) 20
smoking cessation (20) 20
smoking-cessation (19) 19
alkaloids - chemistry (18) 18
analysis (17) 17
azocines - chemistry (17) 17
mecamylamine - pharmacology (17) 17
article (16) 16
nicotinic agonists - therapeutic use (16) 16
ligands (15) 15
middle aged (15) 15
narcotic antagonists - therapeutic use (15) 15
alpha-4-beta-2 (14) 14
brain (14) 14
chemistry, medicinal (14) 14
quinolizines - chemistry (14) 14
smoking (14) 14
sustained-release bupropion (14) 14
biochemistry & molecular biology (13) 13
brain - drug effects (13) 13
brain - metabolism (13) 13
nicotine - administration & dosage (13) 13
proteins (13) 13
research (13) 13
azocines - adverse effects (12) 12
benzazepines - therapeutic use (12) 12
binding (12) 12
biomedicine (12) 12
motor activity - drug effects (12) 12
receptor partial agonist (12) 12
smoking - drug therapy (12) 12
time factors (12) 12
alkaloids (11) 11
alkaloids - administration & dosage (11) 11
analgesics - therapeutic use (11) 11
apoptosis (11) 11
cell line, tumor (11) 11
dopamine (11) 11
efficacy (11) 11
in vitro techniques (11) 11
medicine, general & internal (11) 11
pyridines - pharmacology (11) 11
quinoxalines - therapeutic use (11) 11
receptors, nicotinic - physiology (11) 11
rodents (11) 11
toxicology (11) 11
azocines - metabolism (10) 10
azocines - pharmacokinetics (10) 10
benzazepines - pharmacology (10) 10
bridged bicyclo compounds, heterocyclic - pharmacology (10) 10
calcium - metabolism (10) 10
cell biology (10) 10
double-blind (10) 10
mecamylamine (10) 10
placebo-controlled trial (10) 10
quinolizines - metabolism (10) 10
quinoxalines - pharmacology (10) 10
rats, wistar (10) 10
tobacco use disorder - drug therapy (10) 10
up-regulation (10) 10
antineoplastic agents - pharmacology (9) 9
apoptosis - drug effects (9) 9
benzhydryl compounds - pharmacology (9) 9
bupropion - therapeutic use (9) 9
clinical trials as topic (9) 9
dopamine - metabolism (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5, p. CD006103
Background Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract... 
Smoking [drug therapy] | Varenicline | Humans | RANDOMIZED CONTROLLED-TRIAL | Quinolizines [therapeutic use] | PSYCHIATRIC ADVERSE EVENTS | TOBACCO-DEPENDENCE TREATMENT | Quinoxalines [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Bupropion [therapeutic use] | Nicotine [adverse effects; antagonists & inhibitors] | REPLACEMENT THERAPY | SUSTAINED-RELEASE BUPROPION | Smoking Cessation [methods] | Counseling [methods] | VARENICLINE TREATMENT | METHADONE-MAINTAINED SMOKERS | Randomized Controlled Trials as Topic | Azepines [therapeutic use] | DOUBLE-BLIND PLACEBO | Alkaloids [therapeutic use] | Nicotinic Agonists [adverse effects; therapeutic use] | Azocines [therapeutic use] | LONG-TERM SAFETY | Benzazepines [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Substance Withdrawal Syndrome [prevention & control] | Heterocyclic Compounds with 4 or More Rings [therapeutic use] | Quinolizines - therapeutic use | Azepines - adverse effects | Azocines - therapeutic use | Azocines - adverse effects | Substance Withdrawal Syndrome - prevention & control | Alkaloids - adverse effects | Benzazepines - adverse effects | Smoking - drug therapy | Heterocyclic Compounds, 4 or More Rings - adverse effects | Nicotinic Agonists - therapeutic use | Nicotine - antagonists & inhibitors | Smoking Cessation - methods | Azepines - therapeutic use | Nicotine - adverse effects | Nicotinic Agonists - adverse effects | Heterocyclic Compounds, 4 or More Rings - therapeutic use | Benzazepines - therapeutic use | Counseling - methods | Alkaloids - therapeutic use | Quinolizines - adverse effects | Varenicline - therapeutic use | Bupropion - therapeutic use
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 4, Issue 4, p. CD006103
Journal Article
Journal Article